ACTRN12609001045202
Recruiting
Phase 2
An evaluation of the safety and efficacy of intracoronary selected CD 133+ bone marrow stem cells in cardiac recovery after acute myocardial infarct and left ventricular dysfunction: COMPARE-AMI a randomized controlled double blind clinical study
Miltenyi Biotech Inc.0 sites40 target enrollmentDecember 8, 2009
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Miltenyi Biotech Inc.
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •acute ST\-elevation myocardial infarct successfully reperfused by means of coronary stent implantation and demonstrated a substantial persistent LV dysfunction defined by a LVEF \<50% but \>25% on echocardiography obtained within 48 hours after the successful reperfusion therapy.
Exclusion Criteria
- •known previous myocardial infarct, cardiogenic shock, chronic cardiomyopathy, liver disease, renal failure, concomitant disease with a life expectancy of less than 1 year, alcohol or drug dependency, contraindication for bone marrow (BM) aspiration, blood transfusion in the previous 24 hours, hematopoietic disease, chronic inflammatory disease, malignancy, stroke in the previous 3 months or transient ischemic attack in the previous 24 hours.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Comparison of safety and efficacy of chemical method vs mechanical method in inducing labour pains in a term pregnant motherCTRI/2020/08/027093Dr Maya menon
Not yet recruiting
Phase 4
comparing the efficacy and safety ofintralesional acyclovir in two concentration in common wartsHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissueCTRI/2024/02/063057Dr RPGMC Kangra at Tanda
Completed
Not Applicable
usefulness of IPL in treating melasmaCTRI/2017/08/009529IPGMER and SSKM HOSPITA32
Recruiting
Not Applicable
Investigations on the efficacy and safety of intradermal injection of botulinum toxiDiseases of the skin and subcutaneous tissueKCT0004952Samsung Medical Center23
Withdrawn
Phase 3
Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack (RESUS-AMI)acute myocardial infarction with LVEF< 30%heart attack with heartfailure10011082NL-OMON40846niversity college Cork, Centre for Research in Vascular Biology Bio Sciences Institute15